Medfinder
Back to blog

Updated: January 21, 2026

How to Save Money on Insulin Glargine-Yfgn in 2026: Coupons, Discounts, and Patient Assistance

Author

Peter Daggett

Peter Daggett

Summarize with AI


Overview

Insulin glargine-yfgn (formerly Semglee) doesn't have to break the bank. Here are the best coupons, savings cards, and programs to lower your cost in 2026.

Basal insulin is a non-negotiable, lifelong medication for millions of Americans with diabetes. With Semglee discontinued and patients navigating a new insulin glargine landscape, understanding your savings options is more important than ever. This guide covers every available discount, program, and strategy to reduce your out-of-pocket cost for insulin glargine-yfgn and its alternatives in 2026.

What Does Insulin Glargine-Yfgn Cost in 2026?

The retail price of insulin glargine-yfgn has changed significantly with the arrival of Civica Rx in January 2026. Here's the price landscape:

Civica Rx / CalRx (unbranded glargine-yfgn): $45 for a box of 5 pens. This is the lowest list price for any long-acting insulin product in the US. Recommended max consumer price: $55. Available at participating pharmacies nationwide; CalRx brand in California.

Generic insulin glargine-yfgn (Winthrop): Retail price approximately $60–$115 per 10 mL vial at many pharmacies. Discount cards can lower this significantly.

the free MedFinder savings card: Can lower insulin glargine-yfgn to as low as $20.00 for a 3 mL pen at participating pharmacies.

the free MedFinder savings card: Coupons starting from approximately $70–$92 for a 10 mL vial of insulin glargine-yfgn at participating pharmacies. Prices vary by location.

Option 1: Civica Rx — The Lowest List Price

Civica Rx launched its unbranded insulin glargine-yfgn on January 1, 2026, at a single transparent list price of $45 for a box of five 3 mL pens (100 units/mL). The nonprofit company recommends pharmacies set a maximum consumer price of $55 per box. In California, the product is marketed as CalRx. Civica's product is manufactured by Biocon Biologics under the existing FDA marketing approval, and it carries the same interchangeable designation as Semglee.

This is the best option if you're paying cash and want the lowest per-pen price. At $9 per pen (or $55/5 pens at max consumer price), it is substantially cheaper than previous cash prices for Semglee or Lantus without discounts.

MedFinder savings card

Our free discount card with low prices at 65,000+ pharmacies nationwide. Search your medication, compare the cash price near you, and show the card at the counter to save up to 80%. It's a discount, not insurance, and savings vary by drug and pharmacy. Note: pharmacies can choose not to participate. You can use it whether you find your medication with MedFinder or not.

Option 3: Manufacturer and Savings Programs for Interchangeable Products

Since Semglee is discontinued, the Viatris/Biocon savings card program is also discontinued. However, because insulin glargine-yfgn is interchangeable with Lantus, you may be able to use Lantus savings programs:

Sanofi Valyou Savings Program (Lantus): $35/month for Lantus, available to commercially insured and uninsured patients. Enroll at sanofi.com/US/patients. Lantus is the interchangeable equivalent of insulin glargine-yfgn.

Eli Lilly (Basaglar): Eli Lilly's $35/month cap for Basaglar regardless of insurance status. Requires a new prescription for Basaglar (not interchangeable with glargine-yfgn).

Option 4: Medicare and the $35/Month IRA Insulin Cap

If you have Medicare, the Inflation Reduction Act (IRA) capped insulin cost-sharing at $35 per month for covered insulin products under Part D plans starting in 2024. This means regardless of which formulary tier your insulin glargine product sits on, your monthly copay cannot exceed $35 for a covered insulin.

Note: Medicare Part D plans may or may not cover insulin glargine-yfgn specifically — they typically cover other insulin glargine products such as Lantus. Check your plan's formulary. If covered, the $35 cap applies automatically.

Option 5: Patient Assistance Programs (PAPs)

If you are uninsured or underinsured and cannot afford insulin, patient assistance programs may provide insulin at no cost or very low cost:

Sanofi Patient Connection: Free Lantus for qualifying uninsured patients who meet income requirements. Visit sanofi.com or call 1-888-847-4877.

Lilly Cares Foundation: Free Basaglar and other Lilly insulins for qualifying patients. Visit lillycares.com.

Medicaid: Covers insulin for eligible low-income patients. Check eligibility at healthcare.gov.

Quick Savings Summary

Paying cash? → Civica Rx at $45/5 pens (or the free MedFinder savings card coupon ~$20/pen)

Have commercial insurance + Lantus? → Sanofi Valyou at $35/month

On Medicare? → IRA $35/month cap applies to covered insulin products

Uninsured, low income? → Sanofi Patient Connection or Lilly Cares for free insulin

Once you know which product you're getting, use medfinder to locate which pharmacies near you carry it. And if you're still struggling to find it in stock, read our guide: How to Find Insulin Glargine-Yfgn in Stock Near You.

Frequently Asked Questions

Civica Rx launched unbranded insulin glargine-yfgn pens on January 1, 2026 at $45 for a box of five pens — the lowest list price for any long-acting insulin in the US. SingleCare coupons can also bring the cost to as low as $20 per 3 mL pen at participating pharmacies.

Yes. GoodRx offers discount coupons for insulin glargine-yfgn (and insulin glargine products like Lantus) at participating pharmacies. Prices start around $70–$74 for a 10 mL vial of insulin glargine with GoodRx. Check goodrx.com for pricing at pharmacies in your specific ZIP code.

The Viatris/Biocon Semglee savings card was discontinued along with the Semglee product on December 31, 2025. However, because insulin glargine-yfgn is interchangeable with Lantus, you can use the Sanofi Valyou Savings Program for Lantus at $35/month regardless of insurance status.

Yes. Under the Inflation Reduction Act, Medicare Part D plans must cap insulin cost-sharing at $35 per month for covered insulin products. This cap applies to all covered insulin products regardless of their formulary tier. Check your Part D plan's formulary to confirm which insulin glargine products are covered.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Insulin Glargine-Yfgn also looked for: